Inotek Pharmaceuticals Corp

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Inotek Pharmaceuticals Corp
TickerRCKT
CIK #0001281895
CUSIP77313F106
SectorLife Sciences - Pharmaceutical Preparations
Address131 Hartwell Ave 1St Floor, Suite 105, Lexington, MA 02421
Source [EDGAR]
CIK Filing 2011 - 2024
[0001281895] 10-K
[0001281895] 10-Q
[0001281895] 3
[0001281895] 4
[0001281895] 5
[0001281895] 8-K
[0001281895] SC 13D
[0001281895] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
State Street Corp Rocket Pharmaceuticals Inc [2023-01-31] 5.05
Vanguard Group Inc Rocket Pharmaceuticals Inc [2022-02-10] 5.12
Wellington Management Group LLP Rocket Pharmaceuticals Inc [2022-02-04] 5.42
BlackRock Inc Rocket Pharmaceuticals Inc [2022-02-04] 5.2
Perceptive Advisors LLC Rocket Pharmaceuticals Inc [2021-02-16] 5.6
Price T Rowe Associates Inc /MD/ Rocket Pharmaceuticals Inc [2021-02-16] 5.7
Adage Capital Partners GP LLC Rocket Pharmaceuticals Inc [2019-01-17] 5.35
Boxer Capital LLC Rocket Pharmaceuticals Inc [2018-01-19] 0.0
Tang Capital Partners LP Rocket Pharmaceuticals Inc [2018-01-16] 8.1
RTW Investments LP Rocket Pharmaceuticals Inc [2018-01-16] 46.68
Opaleye Management Inc Inotek Pharmaceuticals Corp [2017-10-06] 11.0
Adage Capital Partners GP LLC Inotek Pharmaceuticals Corp [2017-10-05] 5.55
BML Investment Partners LP Inotek Pharmaceuticals Corp [2017-09-20] 5.5
OrbiMed Advisors LLC Inotek Pharmaceuticals Corp [2017-02-13] 4.68
Great Point Partners LLC Inotek Pharmaceuticals Corp [2017-01-03] 5.07
Citadel Advisors LLC Inotek Pharmaceuticals Corp [2016-08-29] 6.5
Astrazeneca PLC Inotek Pharmaceuticals Corp [2016-02-16] 7.3
RS Investment Management Co LLC Inotek Pharmaceuticals Corp [2016-02-12] 6.0
Rho Ventures IV QP LP Inotek Pharmaceuticals Corp [2016-02-12] 9.9
Franklin Resources Inc Inotek Pharmaceuticals Corp [2016-02-09] 5.8
Prudential Financial Inc Inotek Pharmaceuticals Corp [2016-02-03] 7.3
Jennison Associates LLC Inotek Pharmaceuticals Corp [2016-02-03] 7.3
BlackRock Inc Inotek Pharmaceuticals Corp [2016-01-28] 6.5
Point72 Asset Management LP Inotek Pharmaceuticals Corp [2015-08-24] 2.4
Polygon Management Ltd Inotek Pharmaceuticals Corp [2015-08-03] 6.372
Care Capital III LLC Inotek Pharmaceuticals Corp [2015-03-05] 0.6
Devon Park BioVentures LP Inotek Pharmaceuticals Corp [2015-03-05] 20.42
Form 3/4/5 Filer 2011 - 2024
Rocket Pharmaceuticals Inc
Militello John
Patel Kinnari
Shah Gaurav
White Mark Andrew
Wong Roderick
RTW Investments LP
Schwartz Jonathan David
Wilson Martin
Southwell David P
Malik Fady Ibraham
Makker Gotham
Yalamanchi Naveen
Bjork Elisabeth
Granadillo Pedro P
Boess Carsten
Garcia-Parada Carlos
Alam Kamran
Batchelder Brian
Ritter Dale
Spivey Richard N.
Machado Patrick
Carroll J Martin
Phillips Gary M.
Howes Paul G
Barberich Timothy J
Baumgartner Rudolf A
Devon Park BioVentures LP
Devon Park Associates, L.P.
Devon Park Associates, LLC
McVicar William K.
Rho Ventures IV Holdings LLC
Rho Ventures IV-A, L.P.
Kantesaria Devang
Vogelbaum Martin
Harel Ittai
Karabelas Argeris N
Peimer Isai
Care Capital Offshore Investments III LP
Care Capital Investments III L.P.
Care Capital III LLC
Care Capital Offshore Investments II LP
Care Capital Investments II LP
Care Capital II LLC
MedImmune Ventures, Inc.
Pitango V.C. Fund IV, L.P.
Pitango Venture Capital Fund IV, L.P.
Pitango Venture Capital Principals Fund IV, L.P.
Pitango G.C. Capital Holdings Ltd.
Rho Ventures IV GmbH & Co Beteiligungs KG
Rho Ventures IV QP LP
Rho Management Ventures IV LLC
Rho Capital Partners Verwaltungs GmbH
Leschly Mark
Ruch Joshua
Rho Ventures IV LP
Kairouz Habib
Form 13F Holdings
Firm Period DFND Voting Shares
RTW Investments LP [2023-03-31] SOLE 17,687,772.0 17,687,772.0
BlackRock Inc. [2023-03-31] SOLE 5,337,876.0 5,466,970.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 4,430,864.0
Maverick Capital Ltd [2023-03-31] SOLE 4,407,623.0 4,407,623.0
Wellington Management Group LLP [2023-03-31] DFND 0.0 4,107,928.0
State Street Corp [2023-03-31] DFND 3,904,935.0 4,019,686.0
Westfield Capital Management Co LP [2023-03-31] SOLE 2,897,799.0 3,235,908.0
Citadel Advisors LLC [2023-03-31] DFND 2,685,049.0 2,685,049.0
Price T Rowe Associates Inc /MD/ [2023-03-31] SOLE 331,489.0 1,798,518.0
Goldman Sachs Group Inc [2023-03-31] DFND 1,651,662.0 1,651,727.0
Boxer Capital, LLC [2023-03-31] OTR 1,466,051.0 1,466,051.0
Avidity Partners Management LP [2023-03-31] SOLE 1,244,400.0 1,244,400.0
Dimensional Fund Advisors LP [2023-03-31] SOLE 1,134,366.0 1,192,637.0
Geode Capital Management LLC [2023-03-31] DFND 1,155,739.0 1,155,739.0
RA Capital Management LP [2023-03-31] SOLE 0.0 1,131,775.0
Lord Abbett & Co LLC [2023-03-31] SOLE 995,125.0 1,100,771.0
Cowen and Company LLC [2023-03-31] DFND 1,100,000.0 1,100,000.0
Novo Holdings A/S [2023-03-31] SOLE 920,000.0 920,000.0
Logos Global Management LP [2023-03-31] SOLE 900,000.0 900,000.0
Eventide Asset Management LLC [2023-03-31] SOLE 898,000.0 898,000.0
Cormorant Asset Management LP [2023-03-31] DFND 868,550.0 868,550.0
Perceptive Advisors LLC [2023-03-31] SOLE 867,732.0 867,732.0
BAMCO Inc /NY/ [2023-03-31] DFND 0.0 846,886.0
JPMorgan Chase & Co [2023-03-31] DFND 749,653.0 821,275.0
M28 Capital Management LP [2023-03-31] SOLE 722,080.0 722,080.0
Franklin Resources Inc [2023-03-31] DFND 661,515.0 661,515.0
Putnam Investments LLC [2023-03-31] DFND 628,514.0 628,514.0
Bank of America Corp /DE/ [2023-03-31] DFND 19,852.0 617,157.0
Morgan Stanley [2023-03-31] DFND 555,194.0 592,026.0
Northern Trust Corp [2023-03-31] DFND 24,904.0 546,932.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com